Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne S R van Lindert

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|June 7, 2013
[A man with a 'galaxy sign']Anne S R van Lindert, Anneke van Lieshout, Maarten H van Leuken
Case Reports in Oncology|September 24, 2019
Acute-Onset Pneumonitis while Administering the First Dose of DurvalumabErwin H J Tonk, Anne S R van Lindert, Joost J C Verhoeff, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 26, 2020
Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysisMyra van Laar, Wouter A C van Amsterdam, Anne S R van Lindert, et al.
Anticancer Research|October 3, 2022
Long-term Local Control and Overall Survival After Radiotherapy in Oligoprogressive Patients During Treatment With Checkpoint InhibitorsPim J J Damen, Karijn P M Suijkerbuijk, Anne S R VAN Lindert, et al.
Virchows Archiv : an International Journal of Pathology|November 12, 2022
Nationwide differences in cytology fixation and processing methods and their impact on interlaboratory variation in PD-L1 positivityBregje M Koomen, Mirthe de Boer, Carmen van Dooijeweert, et al.
Acta Oncologica (Stockholm, Sweden)|June 30, 2021
Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapyJoyce E Lodeweges, Peter S N van Rossum, Marcia M T J Bartels, et al.
Cancer Immunology, Immunotherapy : CII|October 4, 2023
Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibitionMick J M van Eijs, Rik J Verheijden, Stefanie A van der Wees, et al.
Clinical Lung Cancer|December 17, 2019
Impact of Lung Cancer Treatment on Cognitive FunctioningHenrieke J van de Kamp, Marthe Te Molder, Karlijn J G Schulkes, et al.
Lung Cancer (Amsterdam, Netherlands)|July 31, 2021
Considerable interlaboratory variation in PD-L1 positivity in a nationwide cohort of non-small cell lung cancer patientsBregje M Koomen, Quirinus J M Voorham, Chantal C H J Epskamp-Kuijpers, et al.
Journal of the National Cancer Institute|November 24, 2023
Physical activity and checkpoint inhibition: association with toxicity and survivalRik J Verheijden, Anna Cabané Ballester, Karel C Smit, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Nederlands Tijdschrift Voor Geneeskunde|June 7, 2013
[A man with a 'galaxy sign']Anne S R van Lindert, Anneke van Lieshout, Maarten H van Leuken
Case Reports in Oncology|September 24, 2019
Acute-Onset Pneumonitis while Administering the First Dose of DurvalumabErwin H J Tonk, Anne S R van Lindert, Joost J C Verhoeff, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 26, 2020
Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysisMyra van Laar, Wouter A C van Amsterdam, Anne S R van Lindert, et al.
Anticancer Research|October 3, 2022
Long-term Local Control and Overall Survival After Radiotherapy in Oligoprogressive Patients During Treatment With Checkpoint InhibitorsPim J J Damen, Karijn P M Suijkerbuijk, Anne S R VAN Lindert, et al.
Virchows Archiv : an International Journal of Pathology|November 12, 2022
Nationwide differences in cytology fixation and processing methods and their impact on interlaboratory variation in PD-L1 positivityBregje M Koomen, Mirthe de Boer, Carmen van Dooijeweert, et al.
Acta Oncologica (Stockholm, Sweden)|June 30, 2021
Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapyJoyce E Lodeweges, Peter S N van Rossum, Marcia M T J Bartels, et al.
Cancer Immunology, Immunotherapy : CII|October 4, 2023
Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibitionMick J M van Eijs, Rik J Verheijden, Stefanie A van der Wees, et al.
Clinical Lung Cancer|December 17, 2019
Impact of Lung Cancer Treatment on Cognitive FunctioningHenrieke J van de Kamp, Marthe Te Molder, Karlijn J G Schulkes, et al.
Lung Cancer (Amsterdam, Netherlands)|July 31, 2021
Considerable interlaboratory variation in PD-L1 positivity in a nationwide cohort of non-small cell lung cancer patientsBregje M Koomen, Quirinus J M Voorham, Chantal C H J Epskamp-Kuijpers, et al.
Journal of the National Cancer Institute|November 24, 2023
Physical activity and checkpoint inhibition: association with toxicity and survivalRik J Verheijden, Anna Cabané Ballester, Karel C Smit, et al.
Pageof 3